Patrick F. Smith, PRESIDENT, INTEGRATED DRUG Development at Certara, Inc. (CERT), sold 10,000 shares at $17.71 ($177K) on 2022-08-16, disclosed to the SEC on 2022-08-18.
Open-market sale of $177k CERT by PRESIDENT, INTEGRATED DRUG Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CERT | SELL | 2024-02-21 | $90K | — | Filing → |
| CERT | SELL | 2023-06-06 | $823K | — | Filing → |
| CERT | SELL | 2022-11-14 | $32K | — | Filing → |